Volume 32, Issue 2 e13173
ORIGINAL ARTICLE

Benefits of multimodal enhanced recovery pathway in patients undergoing kidney transplantation

Kevin A. Espino

Corresponding Author

Kevin A. Espino

Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA

Correspondence

Kevin Espino, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.

Email: [email protected]

Search for more papers by this author
J. Reinier F. Narvaez

J. Reinier F. Narvaez

University at Buffalo Department of Surgery, Buffalo, NY, USA

Search for more papers by this author
Michael C. Ott

Michael C. Ott

Erie County Medical Center Regional Transplantation and Kidney Care Center of Excellence, Buffalo, NY, USA

Search for more papers by this author
Liise K. Kayler

Liise K. Kayler

University at Buffalo Department of Surgery, Buffalo, NY, USA

Erie County Medical Center Regional Transplantation and Kidney Care Center of Excellence, Buffalo, NY, USA

Search for more papers by this author
First published: 08 December 2017
Citations: 26

Abstract

Background

Use of enhanced recovery after surgery (ERAS) pathways to accelerate functional recovery and reduce length of stay (LOS) has rarely been investigated in kidney transplantation (KTX).

Materials and Methods

Consecutive adult isolated KTXs between July 2015 and July 2016 (ERAS, n = 139) were compared with a historical cohort between January 2014 and July 2015 (HISTORIC, n = 95).

Results

Enhanced recovery after surgery recipients were significantly more likely to receive kidneys that were non-local (56.1% vs 4.2%), higher Kidney Donor Profile Index (36-85, 58.4% vs 45.2%; >85, 15.2% vs 10.7%), cold ischemia time ≥30 h (62.4% vs 4.7%), induced with antithymocyte globulin (97.1% vs 87.4%), and to develop delayed graft function (46.4% vs 25.0%). LOS was shorter by 1 day among ERAS (mean 4.59) compared to HISTORIC patients (mean 5.65) predominantly due to a shift in discharges within 3 days (32.4% vs 4.2%); 30-day readmission to the hospital (27.3% vs 27.4%) or emergency room visit (9.4% vs 7.4%) was similar. There was one 30-day death in the ERAS group and none in the HISTORIC group. Return to bowel function and early meal consumption were significantly associated with ERAS, however, with somewhat higher diarrhea and emesis rates.

Conclusion

ERAS following KTX correlated with lower LOS without change in readmissions or ER visits despite higher delayed graft function rates.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.